These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38036196)

  • 1. The role of abnormal ubiquitination in hepatocellular carcinoma pathology.
    Zhang M; Wei T; Guo D
    Cell Signal; 2024 Feb; 114():110994. PubMed ID: 38036196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ubiquitin-specific protease 2a promotes hepatocellular carcinoma progression via deubiquitination and stabilization of RAB1A.
    Xiong B; Huang J; Liu Y; Zou M; Zhao Z; Gong J; Wu X; Qiu C
    Cell Oncol (Dordr); 2021 Apr; 44(2):329-343. PubMed ID: 33074477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis.
    Zhang X; Jin J; Cong J; Chen S; Wang T; Gao B; Huang G; Huang Z; Zhang J; Wang Z; Yang J
    Curr Top Med Chem; 2024; 24(3):179-191. PubMed ID: 38173207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imbalance in ALR ubiquitination accelerates the progression of nonalcoholic steatohepatitis to hepatocellular carcinoma.
    Zheng M; Ai Z; Guo Y; Chen Y; Xie P; An W
    Oncogene; 2023 Jan; 42(4):308-321. PubMed ID: 36434180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing MYH9 blocks HBx-induced GSK3β ubiquitination and degradation to inhibit tumor stemness in hepatocellular carcinoma.
    Lin X; Li AM; Li YH; Luo RC; Zou YJ; Liu YY; Liu C; Xie YY; Zuo S; Liu Z; Liu Z; Fang WY
    Signal Transduct Target Ther; 2020 Feb; 5(1):13. PubMed ID: 32296025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression from cirrhosis to cancer is associated with early ubiquitin post-translational modifications: identification of new biomarkers of cirrhosis at risk of malignancy.
    Laouirem S; Le Faouder J; Alexandrov T; Mestivier D; Léger T; Baudin X; Mebarki M; Paradis V; Camadro JM; Bedossa P
    J Pathol; 2014 Dec; 234(4):452-63. PubMed ID: 24979321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin-proteasome system and its potential application in hepatocellular carcinoma therapy.
    Chen YJ; Wu H; Shen XZ
    Cancer Lett; 2016 Sep; 379(2):245-52. PubMed ID: 26193663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trabid inhibits hepatocellular carcinoma growth and metastasis by cleaving RNF8-induced K63 ubiquitination of Twist1.
    Zhu Y; Qu C; Hong X; Jia Y; Lin M; Luo Y; Lin F; Xie X; Xie X; Huang J; Wu Q; Qiu X; Piao D; Xing Y; Yu T; Lu Y; Huang Q; Yu C; Jin J; Zhang Z
    Cell Death Differ; 2019 Jan; 26(2):306-320. PubMed ID: 29748601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin ligase NEDD4 promotes the proliferation of hepatocellular carcinoma cells through targeting PCDH17 protein for ubiquitination and degradation.
    Liu Z; Hu Q; Hu B; Cao K; Xu T; Hou T; Cao T; Wang R; Shi H; Zhang B
    J Biol Chem; 2024 Jan; 300(1):105593. PubMed ID: 38145746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant lipid metabolism in hepatocellular carcinoma cells as well as immune microenvironment: A review.
    Hu B; Lin JZ; Yang XB; Sang XT
    Cell Prolif; 2020 Mar; 53(3):e12772. PubMed ID: 32003505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intricate effects of post-translational modifications in liver cancer: mechanisms to clinical applications.
    Zhang Y; Xu W; Peng C; Ren S; Zhang C
    J Transl Med; 2024 Jul; 22(1):651. PubMed ID: 38997696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing.
    Chen D; Wang Y; Lu R; Jiang X; Chen X; Meng N; Chen M; Xie S; Yan GR
    Theranostics; 2020; 10(19):8558-8572. PubMed ID: 32754263
    [No Abstract]   [Full Text] [Related]  

  • 14. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
    Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
    Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
    Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
    Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The deubiquitinating enzyme USP19 facilitates hepatocellular carcinoma progression through stabilizing YAP.
    Tian Z; Xu C; He W; Lin Z; Zhang W; Tao K; Ding R; Zhang X; Dou K
    Cancer Lett; 2023 Nov; 577():216439. PubMed ID: 37832781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM31 is upregulated in hepatocellular carcinoma and promotes disease progression by inducing ubiquitination of TSC1-TSC2 complex.
    Guo P; Ma X; Zhao W; Huai W; Li T; Qiu Y; Zhang Y; Han L
    Oncogene; 2018 Jan; 37(4):478-488. PubMed ID: 28967907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitination of UVRAG by SMURF1 promotes autophagosome maturation and inhibits hepatocellular carcinoma growth.
    Feng X; Jia Y; Zhang Y; Ma F; Zhu Y; Hong X; Zhou Q; He R; Zhang H; Jin J; Piao D; Huang H; Li Q; Qiu X; Zhang Z
    Autophagy; 2019 Jul; 15(7):1130-1149. PubMed ID: 30686098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FBXL6 governs c-MYC to promote hepatocellular carcinoma through ubiquitination and stabilization of HSP90AA1.
    Shi W; Feng L; Dong S; Ning Z; Hua Y; Liu L; Chen Z; Meng Z
    Cell Commun Signal; 2020 Jun; 18(1):100. PubMed ID: 32576198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.